SCHEMBL7797823

SCHEMBL7797823

CC(C)(C)c1ccc2c(c1)CCC(=O)C2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.50
CYP1A2 P05177 3/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP11B1 P15538 2/20 0.44
CYP11B2 P19099 2/20 0.44
CYP2C19 P33261 2/20 0.44
ALDH1A1 P00352 4/20 0.39
NPC1 O15118 1/20 0.39
PLA2G1B P04054 1/20 0.39
NFKB1 P19838 1/20 0.39
CASP3 P42574 1/20 0.39
RAB9A P51151 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ATG4B Q9Y4P1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20068166 0.92 CYP2A6 (0.50) CYP2A6CYP1A2CYP3A4CYP2C9CYP11B1
SCHEMBL10203278 0.88 ALDH1A1 (0.41) CYP2A6ALDH1A1NPC1PLA2G1BNFKB1
SCHEMBL6903925 0.86 ALDH1A1 (0.43) CYP1A2CYP2C19ALDH1A1NPC1PLA2G1B
SCHEMBL24126858 0.84 CYP11B1 (0.56) CYP2A6CYP1A2CYP3A4CYP2C9CYP11B1
SCHEMBL27843795 0.82 CYP2A6 (0.40) CYP2A6CYP1A2CYP3A4CYP2C9CYP11B1
SCHEMBL27843775 0.82 CYP2A6 (0.40) CYP2A6CYP1A2CYP3A4CYP2C9CYP11B1
SCHEMBL6903879 0.79 ALDH1A1 (0.44) CYP1A2CYP3A4CYP2C19ALDH1A1NPC1
SCHEMBL6900356 0.77 ALDH1A1 (0.43) CYP1A2CYP2C19ALDH1A1NPC1PLA2G1B
SCHEMBL1701852 0.76 CYP2A6 (0.54) CYP2A6CYP1A2CYP3A4CYP2C9CYP11B1
SCHEMBL10627376 0.75 TRPV1 (0.47) ALDH1A1TP53HPGDALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0591583-B1 Benzo (f) quinolinones as 5-alpha-reductase inhibitors LILLY CO ELI (US) 2001-12-19 EP disclosed
EP-0532190-B1 Benzo(f)quinolinones as 5-alpha-reductase inhibitors LILLY CO ELI (US) 2000-12-27 EP disclosed
EP-0591582-B1 Hexahydrobenzo (f) quinolinones as 5-alpha-reductase inhibitors LILLY CO ELI (US) 1999-01-20 EP disclosed
EP-0531026-B1 Hexahydrobenzo[f]quinolinones as 5-alpha-reductase inhibitors LILLY CO ELI (US) 1998-11-18 EP disclosed
US-5710163-A STEROID 5A-REDUCTASE INHIBITORS ELI LILLY AND COMPANY (US) 1998-01-20 US disclosed
US-5670512-A SKIN DISORDERS; REDUCTASE INHIBITORS ELI LILLY AND COMPANY (US) 1997-09-23 US disclosed
US-5541190-A TREATING BENIGN PROSTATIC HYPERPLASIA, MALE PATTERN BALDNESS, PROSTATIC CANCER, ANDROGENIC ALOPECIA ELI LILLY AND COMPANY (US) 1996-07-30 US disclosed
US-5495021-A STEROID 5 ALPHA-REDUCTASE INHIBITORS ELI LILLY AND COMPANY (US) 1996-02-27 US disclosed
US-5334767-A Steroid 5a-reductase inhibitor ELI LILLY AND COMPANY (US) 1994-08-02 US disclosed
EP-0591583-A1 Benzo (f) quinolinones as 5-alpha-reductase inhibitors ELI LILLY AND COMPANY (US) 1994-04-13 EP disclosed
EP-0591582-A1 Hexahydrobenzo (f) quinolinones as 5-alpha-reductase inhibitors ELI LILLY AND COMPANY (US) 1994-04-13 EP disclosed
US-5250539-A 5-alpha reductase inhibitors; administer as therapy for benign prostatic hyperplasia, hirsutism and acne ELI LILLY AND COMPANY (US) 1993-10-05 US disclosed
US-5239075-A PROCESS FOR THE PREPARATION OF BENZO (F) QUINOLINONES ELI LILLY AND COMPANY (US) 1993-08-24 US disclosed
EP-0532190-A2 Benzo f quinolinones as 5-alpha-reductase inhibitors ELI LILLY AND COMPANY (US) 1993-03-17 EP disclosed
EP-0531026-A1 Hexahydrobenzo[f]quinolinones as 5-alpha-reductase inhibitors ELI LILLY AND COMPANY (US) 1993-03-10 EP disclosed